Cell line · CVCL_1092

BT-549

Cancer cell line, Homo sapiens. Invasive breast carcinoma of no special type. 202 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. BT-549. Cell lines, record CVCL_1092. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1092

On this page

Cell line

As Cellosaurus gives it.

Name: BT-549
Accession: CVCL_1092
RRID: RRID:CVCL_1092
Synonyms: BT 549, BT.549, BT549
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: 72Y
Category: Cancer cell line
Diseases: Invasive breast carcinoma of no special type (NCIt C4194)
Derived from: Breast (in situ)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers202

2 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

Paper	Journal	Year	How we know	Source
VCP-Regulated LMF2 Stabilizes the Cholesterol Biosynthesis Enzyme HMGCS1 to Drive Cancer Progression and Confer Capecitabine Resistance in Triple-Negative Breast Cancer.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
ZBTB1 Regulates Glycolysis and Chemotherapy Resistance Through Interacting with c-Myc in Triple Negative Breast Cancer.	Cancers (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Epigenetic Reactivation of TNFRSF19 Suppresses Mitophagy and Sensitizes Triple-Negative Breast Cancer to Doxorubicin.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.	Cell Rep Med	2026	Its Methods give the RRID and name the line	PubMed
E3 Ubiquitin Ligase Mind Bomb 1 is a Novel Negative Regulator of Tumor-Suppressive BMP Signaling.	Cancer Res Commun	2026	Its Methods give the RRID and name the line	PubMed
Immune-associated alternative splicing signatures define molecular subtypes in breast cancer.	iScience	2026	Its Methods give the RRID and name the line	PubMed
Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma.	Cancer Immunol Res	2026	Its Methods give the RRID and name the line	PubMed
ENO2 sustains cancer stemness and metastatic competence through a phosphoenolpyruvate-dependent metabolic axis in triple-negative breast cancer.	Cell Death Dis	2026	Its Methods give the RRID and name the line	PubMed
Single-cell multi-omics deciphers the myofibro-inflammatory program of cancer-associated fibroblasts in triple-negative breast cancer.	Cell Death Discov	2026	Its Methods give the RRID and name the line	PubMed
The deubiquitinase USP25 contributes to stemness and malignant progression of breast cancer by stabilizing C1ql4.	Sci Rep	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 202

See all 202 papers

Relatives12

Relation	Cell line	Accession	Source
Derived from it	11-9-1-4	CVCL_5948	Cell lines
Derived from it	11-YX-1	CVCL_WG97	Cell lines
Derived from it	BT-549-Dox	CVCL_UJ22	Cell lines
Derived from it	BT-549-Luc	CVCL_J245	Cell lines
Derived from it	BT-549/RFP	CVCL_JY91	Cell lines
Derived from it	EDITGENE BRCA2 Knockout BT-549 Cell Line	CVCL_F6H8	Cell lines
Derived from it	EDITGENE PALB2 Knockout BT-549 Cell Line	CVCL_F6HT	Cell lines
Derived from it	HyCyte BT-549 KO-hARTN	CVCL_F1N2	Cell lines
Derived from it	HyCyte BT-549 KO-hBAD	CVCL_F1N3	Cell lines
Derived from it	HyCyte BT-549 KO-hCD70	CVCL_F1N4	Cell lines

1 to 10 of 12

See all 12 relatives

Cell banks8

Cell bank	Catalog number	Status	Source
ATCC	HTB-122		ATCC
AddexBio	C0006017/4962		Cellosaurus
CLS	300132		CLS
EDITGENE	EDC00379		EDITGENE
IBRC	C10151		Cellosaurus
ICLC	HTL02006		ICLC
KCB	KCB 2011118YJ		Cellosaurus
NCI-DCTD	BT-549	Discontinued	Cellosaurus

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_1092

GET https://conductscience.org/api/cell-lines/v1/CVCL_1092/papers?page=2

API reference For AI assistants